a homegrown opportunity

Sequence Bio is a Newfoundland and Labrador biotechnology company striving to improve how we treat diseases and develop medicines.

Sequence Bio is planning to conduct research in Newfoundland and Labrador, and doing so in an ethical and transparent way is our first priority. Our research efforts require approval by the Health Research Ethics Board (HREB). The words “believe,” “expect,” “anticipate,” and similar expressions, among others, generally identify our intent and/or objective to undertake research in this province and may be subject to change after HREB Review, and will continue to evolve as our business grows.

Therefore, to ensure full compliance with the process, Sequence Bio will not be sharing any information about planned research studies until approved.

Sequence Bio

can we improve healthcare and drug discovery here at home?

It is our goal to launch the 100k Genome Project, a community-based initiative enabling innovative science, in Newfoundland and Labrador.


why newfoundland and labrador?

there's nowhere quite like it

Modern drug discovery relies on the right kind of information: real-world patient data that integrates pan-omics with well-characterized phenotypic information. And while this information isn't found everywhere, it is found in Newfoundland and Labrador.

Icon isolated

unique isolated population

Icon desease

high incidence of rare and complex diseases

Icon electronic records

comprehensive electronic health records

Icon family

extended family pedigrees

Partnership Opportunities

a life-changing approach

We're always looking for exciting partnerships with companies that understand the value of human genetics as a platform for drug discovery and are willing to share our commitment to the people of Newfoundland and Labrador, so get in touch today!


inquire about partnerships

Our Partners
Genotek
Genospace
Gov nl
Genome atlantic
Biotecanada
Mun
The Sequence Crew

meet the team

We're a happy mix from all across Newfoundland and Labrador, with a higher than average affinity for ping-pong. Our kitchen always has some fresh Tetley on the boil and Jam Jam cookies in the cupboard. Get to know us a little more by clicking on our lovely mugs!

We're hiring, join the team

Chris Gardner

CEO & President

Jeremy Grushcow PhD JD

Chief Business Officer

Karen Moores

VP External Affairs

Angela Power

Executive Director, Ethics and Privacy

Gerry Mugford PhD

Director of Research

Sophie Harrington

Director of Marketing

Neala Quigley

Director of Community Engagement

Dan Brake

Director of Technology

Dave Phillips

Director of Finance

Meshari Alwashmi

Research Coordinator

Diane Power

Project Manager, Research Operations

Pekoe

Chief Indifference Officer

Advised by the brightest minds

scientific advisory board

Dr. Euan Ashley

Stanford Medicine

Dr. Pek Lum

Capella Bio

Sequence Bio leadership

board of directors

Chris Gardner

Sequence Bio

Mark Dobbin

Killick Capital

Dr. Andrew Furey

team broken earth

James Hardiman

DCVC

Dcvc
Killick
Klister
Pelorus